Literature DB >> 1617666

Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.

K Takita1, T Sato, M Miyagi, M Watatani, F Akiyama, G Sakamoto, F Kasumi, R Abe, Y Nakamura.   

Abstract

To examine the role of loss of heterozygosity (LOH) during tumor development and/or progression, we looked for correlations between metastasis of breast cancer to a regional lymph node(s) and LOH of chromosomal arms 11p, 13q, 16q, 17p, and 17q, where frequent losses in primary tumors have been detected. No correlation between lymph node metastasis and LOH of chromosomes 13q, 16q, or 17q was observed. However, tumors showing LOH of chromosomes 11p (chi 2 = 10.82, P less than 0.01) and 17p (chi 2 = 6.78, P less than 0.01) revealed a significantly higher incidence of metastasis to a regional lymph node(s) than tumors without LOH on these chromosomal arms. Furthermore, only four of 30 (13%) patients with tumors that retained both 11p and 17p had metastasis to a regional lymph node(s), compared with 24 of 32 (75%) patients with tumors that had lost both 11p and 17p. Analysis of LOH with markers on chromosomes 11p and 17p in a large number of tumors indicated that the peritelomeric region of each of these chromosomal arms contains a tumor suppressor gene that may be associated with tumor progression, particularly metastasis to a regional lymph node(s).

Entities:  

Mesh:

Year:  1992        PMID: 1617666

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil.

Authors:  S C L Santos; L R Cavalli; I J Cavalli; R S Lima; B R Haddad; E M S F Ribeiro
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

2.  Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis.

Authors:  T Tokino; T Urano; T Furuhata; M Matsushima; T Miyatsu; S Sasaki; Y Nakamura
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

3.  Cell invasion of highly metastatic MTLn3 cancer cells is dependent on phospholipase D2 (PLD2) and Janus kinase 3 (JAK3).

Authors:  Karen M Henkels; Terry Farkaly; Madhu Mahankali; Jeffrey E Segall; Julian Gomez-Cambronero
Journal:  J Mol Biol       Date:  2011-03-22       Impact factor: 5.469

Review 4.  Gene therapy for pancreatic cancer targeting the genomic alterations of tumor suppressor genes using replication-selective oncolytic adenovirus.

Authors:  Makoto Sunamura; Masaru Oonuma; Fuyuhiko Motoi; Hisashi Abe; Yukoh Saitoh; Toru Hoshida; Shigeru Ottomo; Akira Horii; Seiki Matsuno
Journal:  Hum Cell       Date:  2002-09       Impact factor: 4.174

5.  Identification of high-risk breast cancer patients from genetic changes of their tumors.

Authors:  M Watatani; H Inui; K Nagayama; Y Imanishi; K Nishimura; Y Hashimoto; E Yamauchi; T Hojo; Y Kotsuma; M Yamato; N Matsunami; M Yasutomi
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

Review 6.  Genetic analysis of breast cancer progression.

Authors:  S H Dairkee; H S Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

Review 7.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

8.  Decreased expression of the DCC gene in human breast carcinoma.

Authors:  K Wakita; N Kohno; Y Sakoda; Y Ishikawa; M Sakaue
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

9.  Lower frequency of allele loss on chromosome 18q in human breast cancer than in colorectal tumors.

Authors:  M Schenk; C Leib-Mösch; I U Schenck; M Jaenicke; S Indraccolo; H D Saeger; G Dallenbach-Hellweg; R Hehlmann
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

10.  Aberrations of the APC gene in primary breast carcinoma.

Authors:  M Kashiwaba; G Tamura; M Ishida
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.